Hold Parameters on Likely Cardiovascular Depressant Medications
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00527709|
Recruitment Status : Unknown
Verified February 2014 by Hackensack University Medical Center.
Recruitment status was: Active, not recruiting
First Posted : September 11, 2007
Last Update Posted : February 4, 2014
This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient.
There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent.
Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?
|Condition or disease|
|Asystole Bradycardia Hypotension|
|Study Type :||Observational|
|Official Title:||Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)|
|Study Start Date :||August 2006|
|Primary Completion Date :||August 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00527709
|United States, New Jersey|
|Hackensack University Medical Center|
|Hackensack, New Jersey, United States, 07601|
|Principal Investigator:||Amit Tailor, MD, MBA||Hackensack University Medical Center|